“…Of the 51 articles in MEDLINE, 7 focused on the treatment of HIC, including bladder instillation with dimethyl sulfoxide solution (DMSO), 68,69 triamcinolone acetonide, 70 tacrolimus, 71 bladder injection with human embryonic stem cell, 72 and the gold standard HIC treatment with fulguration of Hunner's lesion. 73,74 The other 18 studies focused on intravesical therapy of NHIC, including analysis and interpretation of published data showing cure of IC/BPS by uterosacral ligament repair, 75 clorpactin instillation, 76 intravesical hyaluronic acid (HA) instillation [77][78][79] or botulinum toxin-A (BoNT-A) injection [80][81][82][83][84] or combined treatment, 85 intravesical lidocaine instillation, 86,87 DMSO instillation, 88,89 intravesical injections of platelet-rich plasma (PRP), 90 comparison of autonomic responses in different anesthesia types, 91 and stem cell treatment. 92 Results of most studies proved that BoNT-A can decrease the exocytosis of proinflammatory and excitatory neurotransmitters and neuropeptides, such as substance P, from primary afferent fibers that transmit nociceptive pain and participate in the development of peripheral and central sensitizations and decreases the insertion of pain-sensitive ion channels.…”